A New Strategy for Fighting Biological Terrorism

When a terrorist cult released lethal sarin gas in a crowded Tokyo subway in 1995--killing 12 people and making hundreds of others ill--police, fire, and emergency rescue teams rushed to the scene to treat and evacuate those who were ill and to contain the damage. In that case, it was apparent immediately that a toxic substance had been released. But what would have happened if the terrorists had released deadly organisms such as those that cause smallpox or anthrax? A microbe released in

Written byDonald Henderson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

When a terrorist cult released lethal sarin gas in a crowded Tokyo subway in 1995--killing 12 people and making hundreds of others ill--police, fire, and emergency rescue teams rushed to the scene to treat and evacuate those who were ill and to contain the damage. In that case, it was apparent immediately that a toxic substance had been released. But what would have happened if the terrorists had released deadly organisms such as those that cause smallpox or anthrax?

A microbe released into the atmosphere would be invisible, odorless, and tasteless. The attack probably would not be discovered until days or even weeks later, when sick people would begin arriving in emergency rooms and doctors' offices. Rather than being contained at the attack site, diseases would spread far beyond those who were originally exposed. Such biological weapons, in terms of their potential destructiveness and the panic and civil disorder that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies